Nobilis Therapeutics’ NBTX-001 shows promise in treatment of patients with Panic Disorder
14 juin 2017 13h34 HE
|
Nobilis Therapeutics, Inc.
PORTLAND, Ore., June 14, 2017 (GLOBE NEWSWIRE) -- Nobilis Therapeutics, Inc. announced today that the results of the clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic in...